· Periodic Report
Q3 revenue KRW 2.4 billion, operating loss KRW 4.2 billion
Mezion sold KRW 2.4 billion in Q3 and lost KRW 4.2 billion from its main business; sales rose 13.7% from a year earlier and 9.9% from the previous quarter.
140410 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Mezion sold KRW 2.4 billion in Q3 and lost KRW 4.2 billion from its main business; sales rose 13.7% from a year earlier and 9.9% from the previous quarter.
Get app alerts for new disclosures from Mezzion Pharma Co., Ltd..